» Articles » PMID: 21867822

Diagnosis of Ventilator-associated Respiratory Infections (VARI): Microbiologic Clues for Tracheobronchitis (VAT) and Pneumonia (VAP)

Overview
Journal Clin Chest Med
Specialty Pulmonary Medicine
Date 2011 Aug 27
PMID 21867822
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Intubated patients are at risk of bacterial colonization and ventilator-associated respiratory infection (VARI). VARI includes tracheobronchitis (VAT) or pneumonia (VAP). VAT and VAP caused by multidrug-resistant (MDR) pathogens are increasing in the United States and Europe. In patients with risk factors for MDR pathogens, empiric antibiotics are often initiated for 48 to 72 hours pending the availability of pathogen identification and antibiotic sensitivity data. Extensive data indicate that early, appropriate antibiotic therapy improves outcomes for patients with VAP. Recognizing and treating VARI may allow earlier appropriate therapy and improved patient outcomes.

Citing Articles

Ventilator-associated pneumonia: pathobiological heterogeneity and diagnostic challenges.

Howroyd F, Chacko C, MacDuff A, Gautam N, Pouchet B, Tunnicliffe B Nat Commun. 2024; 15(1):6447.

PMID: 39085269 PMC: 11291905. DOI: 10.1038/s41467-024-50805-z.


Ventilator-Associated Lower Respiratory Tract Infections and Their Association With COVID-19: A Retrospective Cohort Study in a Portuguese Intensive Treatment Unit.

Fernandes A, Patricio J, Jorge R, Nazareth R, Pereira C Cureus. 2024; 16(2):e54108.

PMID: 38487146 PMC: 10938268. DOI: 10.7759/cureus.54108.


Treatment and Management of Pneumonia: Lessons Learned from Recent World Event.

Rangel K, De-Simone S Infect Drug Resist. 2024; 17:507-529.

PMID: 38348231 PMC: 10860873. DOI: 10.2147/IDR.S431525.


Rapid Point-of-Care PCR Testing of Drug-Resistant Strains on Endotracheal Aspirate Samples: A Repurposed Effective Tool in the Stepwise Approach of Healthcare-Acquired Pneumonia-A Pilot Study.

Balan A, Bodolea C, Nemes A, Craciun R, Hagau N Int J Mol Sci. 2023; 24(17).

PMID: 37686203 PMC: 10487584. DOI: 10.3390/ijms241713393.


Trends in Molecular Diagnosis of Nosocomial Pneumonia Classic PCR vs. Point-of-Care PCR: A Narrative Review.

Balan A, Bodolea C, Tranca S, Hagau N Healthcare (Basel). 2023; 11(9).

PMID: 37174887 PMC: 10177880. DOI: 10.3390/healthcare11091345.


References
1.
Klompas M . Does this patient have ventilator-associated pneumonia?. JAMA. 2007; 297(14):1583-93. DOI: 10.1001/jama.297.14.1583. View

2.
Pelosi P, Barassi A, Severgnini P, Gomiero B, Finazzi S, Merlini G . Prognostic role of clinical and laboratory criteria to identify early ventilator-associated pneumonia in brain injury. Chest. 2008; 134(1):101-8. DOI: 10.1378/chest.07-2546. View

3.
Nseir S, Favory R, Jozefowicz E, Decamps F, Dewavrin F, Brunin G . Antimicrobial treatment for ventilator-associated tracheobronchitis: a randomized, controlled, multicenter study. Crit Care. 2008; 12(3):R62. PMC: 2481443. DOI: 10.1186/cc6890. View

4.
Pugin J . Clinical signs and scores for the diagnosis of ventilator-associated pneumonia. Minerva Anestesiol. 2002; 68(4):261-5. View

5.
Inglis T, Millar M, Jones J, Robinson D . Tracheal tube biofilm as a source of bacterial colonization of the lung. J Clin Microbiol. 1989; 27(9):2014-8. PMC: 267729. DOI: 10.1128/jcm.27.9.2014-2018.1989. View